Stock Purchase Agreement

A Stock Purchase Agreement in the United States governs the sale and transfer of property between buyer and seller and the obligations of each.

The legal framework for stock purchase transactions involves both federal securities law and state corporate law. Under the Securities Act of 1933, the sale of stock constitutes a securities transaction that must either be registered with the SEC or qualify for an exemption from registration, most commonly under Section 4(a)(2) (private placement exemption) or Regulation D. State blue sky laws impose additional registration or exemption requirements that vary by jurisdiction. The Hart-Scott-Rodino Antitrust Improvements Act of 1976 (15 U.S.C. Section 18a) requires pre-merger notification to the FTC and DOJ for transactions exceeding specified size thresholds, currently $111.4 million (adjusted annually).

The critical distinction between stock purchases and asset purchases lies in liability succession. In a stock purchase, the buyer acquires the company with all of its existing liabilities, including unknown or contingent liabilities, environmental obligations, tax exposures, and pending litigation. This makes complete due diligence and strong representation and warranty provisions essential components of any stock purchase agreement.

A stock purchase agreement is essential whenever an individual or entity acquires ownership shares in a private corporation, whether purchasing a controlling interest, a minority stake, or the entire company. Business acquisitions where the buyer wants to preserve the target company's contracts, licenses, permits, and customer relationships in their existing form are best structured as stock purchases because the corporate entity continues to exist with no change in its contractual obligations. This is particularly important when the target holds non-assignable government contracts, professional licenses, or franchise agreements that would terminate upon asset transfer.

Succession planning transactions where a business owner sells their shares to a family member, key employee, or management team require stock purchase agreements that address valuation methodology, payment terms (often including seller financing over multiple years), and transition period obligations. Private equity and venture capital investments involving the purchase of existing shares from founders or early investors (secondary transactions) need SPAs that coordinate with existing shareholder agreements, investor rights agreements, and any right of first refusal or co-sale provisions.

Partner buyouts in closely held corporations where one shareholder acquires another's interest need stock purchase agreements that implement the buy-sell provisions of the shareholder agreement, establish fair market value through agreed-upon valuation methods, and address the tax implications for both the selling and purchasing shareholders. Cross-border acquisitions involve additional complexity including CFIUS review requirements under the Foreign Investment Risk Review Modernization Act (FIRRMA) for foreign buyers acquiring U.S. businesses in sensitive industries.

The purchase price section must specify the total consideration, the price per share, the number and class of shares being purchased, and the payment structure. Common payment mechanisms include cash at closing, installment payments secured by the purchased shares, promissory notes with interest rates and amortization schedules, earnout provisions tied to post-closing financial performance, and escrow arrangements where a portion of the purchase price is held in escrow to secure the seller's indemnification obligations. The agreement should define the working capital adjustment mechanism, where the final purchase price is adjusted based on the company's working capital at closing compared to a target amount.

Representations and warranties form the backbone of buyer protection in any SPA. The seller typically represents the accuracy of financial statements, the absence of undisclosed liabilities, compliance with laws and regulations, the validity of material contracts, ownership of intellectual property, the status of employee benefits plans under ERISA, environmental compliance under CERCLA and state environmental laws, and the absence of material adverse changes since the last financial statement date. Each representation should be qualified by disclosure schedules that identify known exceptions. The survival period for representations and warranties (typically 12 to 24 months post-closing) and the indemnification caps (commonly 10 to 20 percent of the purchase price for general representations, with fundamental representations surviving longer with higher caps) are heavily negotiated terms.

Closing conditions specify what must occur before the transaction can be completed, including regulatory approvals, third-party consents, completion of due diligence to the buyer's satisfaction, and delivery of required legal opinions. Post-closing covenants typically include the seller's non-competition and non-solicitation obligations for a defined period, transition services the seller will provide, and cooperation with post-closing tax filings. The indemnification section should detail the procedures for making claims, the basket or deductible amount below which claims are not payable, the cap on total indemnification liability, and whether indemnification is the exclusive remedy or whether the buyer preserves rights to bring fraud claims outside the indemnification framework.